QHP Capital completes $1.1bn continuation fund for Azurity Pharmaceuticals
Thursday, March 19, 2026 · first reported by PE Hub
QHP Capital closed a $1.1B continuation fund for Azurity Pharmaceuticals with HarbourVest Partners leading and Pantheon Ventures participating. The fund demonstrates strong LP demand for continuation vehicles in healthcare PE.
- Firm
- QHP Capital
- Also named
- HarbourVest Partners, Pantheon Ventures
- Fund
- Azurity Pharmaceuticals continuation fund
- Size
- $1.1B
- Stage
- Final close
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Apax Sets $13.5 Billion Target for Fund XIIWSJ
- Investcorp closes second North American PE fund at $1.22bnAlternatives Watch +1
- TPG Gets $10 Billion for Climate PE Fund; to Close for New CashBloomberg +2
- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- Ares raises $1.15bn for PE secondaries Fund IThe Secondary Brief
- Thompson Street targets $1.7bn for seventh flagship fundBuyouts Insider